StimGuard appoints new chief financial officer
StimGuard today said it appointed Stephen Deitsch as chief financial officer, effective Jan. 15.
Deitsch has 20 years of corporate financial leadership experience in medtech and healthcare. He replaces interim chief financial officer Gil Bao, who will transition into the role of director of strategy.
“We are excited that Steve will be joining StimGuard’s executive team as chief financial officer,” founder and CEO Laura Perryman said in a news release. “Steve is an accomplished financial executive in our industry, and his leadership experience and demonstrated track record of increasing shareholder value will be key as we transition to commercial stage and bring our differentiated and leading-edge CAN-Stim System to the U.S. urology market in 2020. Steve will nicely complement the recently announced StimGuard executive leadership team, that was previously successful in leading Stimwave a pain management venture to an annualized revenue run-rate of over $40 million.”
Read the entire article here: https://www.massdevice.com/stimguard-appoints-new-chief-financial-officer/